You are here

Lonza maintains 2019 outlook after 'solid start' in Q1

Singapore

SWISS drug ingredients maker Lonza Group is maintaining its full-year outlook amid positive momentum in its core healthcare businesses and headwinds in its speciality ingredients segment, the company said in a business update provided on Thursday.

The company described...

sentifi.com

Market voices on: